Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Antibiotic Dosing in Chronic Kidney Disease and End-Stage Renal Disease: A Focus on Contemporary Challenges.

Vilay AM.

Adv Chronic Kidney Dis. 2019 Jan;26(1):61-71. doi: 10.1053/j.ackd.2018.10.006. Review.

PMID:
30876619
2.

Awareness, self-management behaviors, health literacy and kidney function relationships in specialty practice.

Devraj R, Borrego ME, Vilay AM, Pailden J, Horowitz B.

World J Nephrol. 2018 Jan 6;7(1):41-50. doi: 10.5527/wjn.v7.i1.41.

3.

Psychotherapeutic Agents in End-Stage Renal Disease.

Eyler RF, Unruh ML, Quinn DK, Vilay AM.

Semin Dial. 2015 Jul-Aug;28(4):417-26. doi: 10.1111/sdi.12370. Epub 2015 Apr 6. Review.

PMID:
25857865
4.

Iohexol transmembrane clearance during modeled continuous renal replacement therapy.

Yardman-Frank JM, Mercier RC, Wong CS, Vilay AM.

Blood Purif. 2015;39(1-3):188-92.

PMID:
25765443
5.

Relationship between Health Literacy and Kidney Function.

Devraj R, Borrego M, Vilay AM, Gordon EJ, Pailden J, Horowitz B.

Nephrology (Carlton). 2015 May;20(5):360-7. doi: 10.1111/nep.12425.

PMID:
25661456
6.

Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.

Kesner JM, Yardman-Frank JM, Mercier RC, Wong CS, Walker SE, Argyres DP, Vilay AM.

Blood Purif. 2014;38(3-4):195-202. doi: 10.1159/000368884. Epub 2014 Dec 16.

PMID:
25531772
7.

Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.

Dilworth TJ, Leonard SN, Vilay AM, Mercier RC.

Clin Ther. 2014 Oct 1;36(10):1334-44. doi: 10.1016/j.clinthera.2014.06.027. Epub 2014 Jul 25.

PMID:
25066667
8.

In vitro glucose kinetics during continuous renal replacement therapy: implications for caloric balance in critically ill patients.

Stevenson JM, Heung M, Vilay AM, Eyler RF, Patel C, Mueller BA.

Int J Artif Organs. 2013 Dec;36(12):861-8. doi: 10.5301/ijao.5000232. Epub 2013 Oct 2.

PMID:
24366837
9.

Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.

Eyler RF, Vilay AM, Nader AM, Heung M, Pleva M, Sowinski KM, DePestel DD, Sörgel F, Kinzig M, Mueller BA.

Antimicrob Agents Chemother. 2014;58(3):1320-6. doi: 10.1128/AAC.02090-12. Epub 2013 Dec 9.

10.

Vibration enhances clearance of solutes with varying molecular weights during in vitro hemodialysis.

Mueller BA, Jasiak KD, Thiel SR, Stevenson JM, Vilay AM, Scoville BA, Churchwell MD, Pasko DA, Perkins N.

ASAIO J. 2013 Mar-Apr;59(2):140-4. doi: 10.1097/MAT.0b013e3182837ff0.

PMID:
23438776
11.

Indicators for serious kidney complications associated with toxic exposures: an analysis of the National Poison Data System.

Vilay AM, Wong CS, Schrader RM, Mercier RC, Seifert SA.

Clin Toxicol (Phila). 2013 Feb;51(2):96-105. doi: 10.3109/15563650.2012.762456. Epub 2013 Jan 19.

12.

Intradialytic oral nutritional supplements improve quality of life.

Vilay AM, Mueller BA.

Am J Kidney Dis. 2013 Feb;61(2):349. doi: 10.1053/j.ajkd.2012.11.036. No abstract available.

PMID:
23318013
13.

Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose.

Harder JL, Heung M, Vilay AM, Mueller BA, Segal JH.

Hemodial Int. 2011 Jul;15(3):412-5. doi: 10.1111/j.1542-4758.2011.00563.x. Epub 2011 Jun 15.

14.

Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.

Vilay AM, Grio M, Depestel DD, Sowinski KM, Gao L, Heung M, Salama NN, Mueller BA.

Crit Care Med. 2011 Jan;39(1):19-25. doi: 10.1097/CCM.0b013e3181fa36fb. Erratum in: Crit Care Med. 2011 May;39(5):1247.

PMID:
20890189
15.

Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapies.

Vilay AM, Shah KH, Churchwell MD, Patel JH, DePestel DD, Mueller BA.

Blood Purif. 2010;30(1):37-43. doi: 10.1159/000316685. Epub 2010 Jun 24.

PMID:
20588011
16.

Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.

Vilay AM, Mueller BA, Haines H, Alten JA, Askenazi DJ.

Pharmacotherapy. 2010 Jan;30(1):111. doi: 10.1592/phco.30.1.111.

PMID:
20030480
17.

Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients.

Scott MK, Shah NA, Vilay AM, Thomas J 3rd, Kraus MA, Mueller BA.

J Ren Nutr. 2009 Mar;19(2):145-52. doi: 10.1053/j.jrn.2008.08.004.

PMID:
19218041
18.

Ertapenem clearance during modeled continuous renal replacement therapy.

Stevenson JM, Patel JH, Churchwell MD, Vilay AM, Depestel DD, Sörgel F, Kinzig M, Jakob V, Mueller BA.

Int J Artif Organs. 2008 Dec;31(12):1027-34.

PMID:
19115194
19.

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

Vilay AM, Churchwell MD, Mueller BA.

Crit Care. 2008;12(6):235. doi: 10.1186/cc7093. Epub 2008 Nov 12. Review.

Supplemental Content

Loading ...
Support Center